Metagenomi, Inc. (NASDAQ: MGX) reported Q3 EPS of ($0.51), $0.24 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $11.51 million.

For earnings history and earnings-related data on Metagenomi, Inc. (MGX) click here.